• Explore /
  • Poster
  • / ELARA: A phase II, single-arm, multicenter, open-label trial investigating the efficacy and safety of tisagenlecleucel in adult patients with refractory/relapsed follicular lymphoma (r/r FL).

ELARA: A phase II, single-arm, multicenter, open-label trial investigating the efficacy and safety of tisagenlecleucel in adult patients with refractory/relapsed follicular lymphoma (r/r FL).

Abstract Poster

Authors

null

Michael Dickinson

Peter MacCallum Cancer Centre, Melbourne, Australia

Michael Dickinson , Leslie Popplewell , Arne Kolstad , Joy Ho , Takanori Teshima , Martin H. Dreyling , Stephen J. Schuster , Catherine Thieblemont , Nigel Yateman , Katja Lehnhoff , Tomasz Lawniczek , Lida Bubuteishvili-Pacaud , Nathan Hale Fowler

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Non-Hodgkin Lymphoma

Clinical Trial Registration Number

NCT03568461

Citation

J Clin Oncol 37, 2019 (suppl; abstr TPS7573)

DOI

10.1200/JCO.2019.37.15_suppl.TPS7573

Abstract #

TPS7573

Poster Bd #

323b

Abstract Disclosures

Similar Posters

First Author: Andrew David Zelenetz

First Author: Zhong Zheng

First Author: Pier Luigi Zinzani

First Author: Philippe Armand